SCHEMBL4061139

SCHEMBL4061139

O=C(O)CCC(Br)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 3/20 0.48
▸ CYP2C19 P33261 2/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ CES2 O00748 2/20 0.48
▸ CES1 P23141 2/20 0.48
▸ CPA3 P15088 1/20 0.47
▸ NAALAD2 Q9Y3Q0 1/20 0.46
▸ KEAP1 Q14145 1/20 0.43
▸ MAPK1 P28482 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ GLA P06280 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ ALOX12 P18054 1/20 0.42
▸ NFKB1 P19838 1/20 0.42
▸ APEX1 P27695 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28160684 0.88 HDAC3 (0.47) CYP2D6CYP2C19ALDH1A1CYP1A2TSHR
SCHEMBL7406300 0.84 ALDH1A1 (0.47) CYP2D6CYP2C19ALDH1A1CES2CES1
SCHEMBL3674189 0.80 CYP2D6 (0.54) CYP2D6CYP2C19ALDH1A1CYP1A2TSHR
SCHEMBL22042211 0.79 HRH1 (0.46) TSHRCES2CES1
SCHEMBL27305718 0.79 CYP2C19 (0.48) CYP2D6CYP2C19ALDH1A1CYP1A2TSHR
SCHEMBL777871 0.78 GABBR2 (0.53) CYP2D6CYP2C19CES2CES1CPA3
SCHEMBL14360103 0.78 GABBR2 (0.53) CYP2D6CYP2C19ALDH1A1CYP1A2TSHR
SCHEMBL26269478 0.78 TAAR1 (0.53) CYP2D6CYP2C19ALDH1A1CYP1A2TSHR
SCHEMBL29756122 0.77 CYP3A4 (0.48) CYP2D6CYP2C19ALDH1A1TSHRPOLB
SCHEMBL8107873 0.77 RIPK1 (0.52) CYP2D6CYP2C19ALDH1A1CYP1A2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2033635-A1 Short-chain fatty acid derivatives for treating pruritus Asan Laboratories Company (Cayman) Limited (CN) 2009-03-11 — — EP claimed
US-20080107646-A1 Administering phenylbutyric acid derivative and pharmaceutically acceptable carrier Sunny Pharmtech Inc. (TW) 2008-05-08 — — US claimed
US-6403646-B1 ADMINISTERING PHENYLBUTYRIC ACID OR DERIVATIVES TO TREAT LIVER DISEASE AND EMPHYSEMA CAUSED BY PROTEASE INHIBITOR TYPE Z MUTATION; STIMULATES SECRETION WITHOUT INCREASING SYNTHESIS OF PROTEIN PERLMUTTER DAVID H (US) 2002-06-11 — — US claimed
US-8846039-B2 Method for ameliorating pruritus ASAN LABORATORIES COMPANY (CAYMAN), LIMITED (TW) 2014-09-30 — — US disclosed
CN-101380317-B Pharmaceutical composition for relieving pruritus CAYMAN ISLAND SHANGANSHENG DEV PHARMACEUTICAL CO LTD 2010-12-08 — — CN disclosed
EP-2033635-A1 Short-chain fatty acid derivatives for treating pruritus Asan Laboratories Company (Cayman) Limited (CN) 2009-03-11 — — EP disclosed
CN-101380317-A Pharmaceutical composition for relieving pruritus CAYMAN ISLAND SHANGANSHENG DEV (CN) 2009-03-11 — — CN disclosed
EP-2030616-A1 Short-chain fatty acid derivatives for treating pruritus Asan Laboratories Company (Cayman) Limited (CN) 2009-03-04 — — EP disclosed
US-20080107646-A1 Administering phenylbutyric acid derivative and pharmaceutically acceptable carrier Sunny Pharmtech Inc. (TW) 2008-05-08 — — US disclosed
US-6403646-B1 ADMINISTERING PHENYLBUTYRIC ACID OR DERIVATIVES TO TREAT LIVER DISEASE AND EMPHYSEMA CAUSED BY PROTEASE INHIBITOR TYPE Z MUTATION; STIMULATES SECRETION WITHOUT INCREASING SYNTHESIS OF PROTEIN PERLMUTTER DAVID H (US) 2002-06-11 — — US disclosed
CN-1134705-A Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases CHIROSCIENCE LTD (GB) 1996-10-30 — — CN disclosed
US-4808741-A Process for preparing carboxyalkyl dipeptides TORCAN CHEMICAL LTD. (CA) 1989-02-28 — — US disclosed
US-4141734-A SUBSTITUTED ORGANIC DI- OR TRISULFIDE ANTIDEPOSIT AGENTS CIBA-GEIBY AG (CH) 1979-02-27 — — US disclosed
Send feedback